Cassava Sciences Stock Clears Benchmark, Hitting 80-Plus RS Rating
The Relative Strength (RS) Rating for Cassava Sciences (SAVA) entered a new percentile Thursday, with a rise from 77 to 85. When looking for the best stocks…
Source: biztoc.com
Page 41 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cassava Sciences Today - Breaking & Trending Today
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
Today, shareholders in Cassava Sciences and SAVA stock are cheering some positive research data for its key drug candidate.
Source: investorplace.com
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
One-Stop Business and Finance News
Source: biztoc.com
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
New in vitro data from Europe show that simufilam can reverse altered filamin A protein in pituitary tumor cells, leading to improved cell signaling.Data suggest FLNA is a central factor influencing... | May 8, 2023
Source: marketscreener.com
Cassava Sciences (NASDAQ:SAVA) Posts Earnings Results, Misses Estimates By $0.02 EPS
Cassava Sciences (NASDAQ:SAVA – Get Rating) announced its earnings results on Monday. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.56) by ($0.02), MarketWatch Earnings reports. Cassava Sciences Stock Performance Shares of NASDAQ:SAVA opened at $23.34 on Tuesday. The stock has a market capitalization of $974.42 million, a price-to-earnings ratio […]
Source: themarketsdaily.com